patient survey - Neuroendocrine Cancer UK

Share Your Neuroendocrine Cancer Diagnosis Journey and Help Shape the Future of Care

by Beth Chesser | Aug 28, 2026

For many people living with neuroendocrine cancer, the journey to diagnosis can be long, complex and filled with uncertainty. Symptoms are often difficult to recognise, may be attributed to other conditions, or can be overlooked before the correct diagnosis is finally...

Help Shape the Future of Neuroendocrine Cancer Research – Share Your Priorities Today

by Clare Gerrard | Dec 8, 2025

Neuroendocrine Cancer UK and UKINETS are jointly leading a James Lind Alliance (JLA) Priority Setting Partnership (PSP) to identify the most important unanswered questions in the diagnosis, treatment and care of neuroendocrine cancers. This national initiative places...

Neuroendocrine Cancer community took part in Cancer 52 COVID-19 patient survey

by Leanne Talbot | Mar 17, 2021

The Neuroendocrine Cancer community were invited to and took part in Cancer 52 second patient survey looking at the impact of the Covid-19 pandemic on people with rare and less common cancers ran from early December 2020 to mid-January 2021. Over 500 people, with a...

Share Your Neuroendocrine Cancer Diagnosis Journey and Help Shape the Future of Care

Help Shape the Future of Neuroendocrine Cancer Research – Share Your Priorities Today

Neuroendocrine Cancer community took part in Cancer 52 COVID-19 patient survey

About Us

Subscribe

Contact

Helpline: 0800 434 6476

Office: 01926 883 487

Holly House, 74 Upper Holly Walk, Leamington Spa CV32 4JL

Email us